Neonatal presentation of adult-onset type II citrullinemia

T. Ohura, K. Kobayashi, Y. Tazawa, I. Nishi, D. Abukawa, O. Sakamoto, K. Iinuma, T. Saheki

Research output: Contribution to journalArticlepeer-review

118 Citations (Scopus)


Adult-onset type II citrullinemia (CTLN2) is characterized by a liver-specific argininosuccinate synthetase deficiency caused by a deficiency of the citrin protein encoded by the SLC25A13 gene. Until now, however, no SLC25A13 mutations have been reported in children with liver diseases. We described three infants who presented as neonates with intrahepatic cholestasis associated with hypermethioninemia or hypergalactosemia detected by neonatal mass screening. DNA analyses of SLC25A13 revealed that one patient was a compound heterozygote for the 851del4 and IVS11+1G→A mutations and two patients (siblings) were homozygotes for the IVS11+1G→A mutation. These results suggested that there may be a variety of liver diseases related to CTLN2 in children.

Original languageEnglish
Pages (from-to)87-90
Number of pages4
JournalHuman Genetics
Issue number2
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Neonatal presentation of adult-onset type II citrullinemia'. Together they form a unique fingerprint.

Cite this